Transcranial direct current stimulation (tDCS) as an additional treatment to cognitive behavior group therapy in adults with tobacco dependence - a double-blind, randomized, sham-controlled pilot trial.

Psychiatry ResMay 13, 2026 (epub)
Clinical ResearchPsychiatry

Stephan Goerigk, Gerrit Burkhardt, Frank Padberg et al.

✦ AI-curated · Sources linked

In 30 seconds

This double-blind, randomized, sham-controlled pilot trial evaluated the efficacy of transcranial direct current stimulation (tDCS) as an adjunct to cognitive behavioral therapy (CBT) in adults with tobacco dependence. Conducted in Germany, the study found that at 6 months, 50% of participants receiving active tDCS achieved abstinence compared to 26% in the sham group, with an odds ratio of 1.66.

Key findings

  • At 6 months, 50% of the active tDCS group were abstinent compared to 26% in the sham group.
  • The odds ratio for abstinence in the active tDCS group was 1.66 (95% CI = 1.02 to 2.70).
  • No serious adverse events were reported during the trial.

Why it matters

The study suggests that tDCS may enhance the effectiveness of CBT for smoking cessation, potentially offering a new adjunctive treatment option for tobacco dependence. Understanding its role could improve cessation strategies.

Source

Published in Psychiatry Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.